Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials

被引：0
|
作者：
Khoury, Thaer [1 ]
Jabbour, Nashwan [2 ]
Peng, Xuan [3 ]
Yan, Li [1 ]
Quinn, Marie [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Lexington, KY USA
[3] Roswell Pk Canc Inst, Snyder, NY USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
179
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies
    Roses, Robert E.
    Kuerer, Henry M.
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (03) : 182 - 188
  • [42] The role of clinical trials in changing therapy for ductal carcinoma in situ
    William C. Wood
    Annals of Surgical Oncology, 2004, 11 : 24S - 27S
  • [43] Borderline Ductal Epithelial Lesions: Interobserver Reproducibility in 43 Cases with Original Diagnosis of Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In-Situ
    Tozbikian, G.
    Brogi, E.
    Catalano, J.
    Patil, S.
    Van Zee, K. J.
    Kadivar, M.
    Vallejo, C. E.
    Wen, Y. H.
    MODERN PATHOLOGY, 2013, 26 : 72A - 72A
  • [44] Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions
    Khoury, Thaer
    CANCERS, 2022, 14 (03)
  • [45] Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
    Guan, Hong
    Sun, Yanhua
    Zan, Qin
    Xu, Meiquan
    Li, Yuan
    Zhou, Ji
    He, Ellen
    Eriksson, Staffan
    Wen, Wen
    Skog, Sven
    MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 923 - 929
  • [46] Borderline Ductal Epithelial Lesions: Interobserver Reproducibility in 43 Cases with Original Diagnosis of Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In-Situ
    Tozbikian, G.
    Brogi, E.
    Catalano, J.
    Patil, S.
    Van Zee, K. J.
    Kadivar, M.
    Vallejo, C. E.
    Wen, Y. H.
    LABORATORY INVESTIGATION, 2013, 93 : 72A - 72A
  • [47] Comparison of rate limiting factors in the transformation of atypical ductal hyperplasia and ductal carcinoma in situ of the breast using immunochemistry and fluorescence in situ hybridization
    Turbat-Herrera, EA
    Nordberg, ML
    deBenedetti, A
    Lampejo, OT
    MODERN PATHOLOGY, 2003, 16 (01) : 50A - 50A
  • [48] Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast
    Mutasa, Simukayi
    Chang, Peter
    Nemer, John
    Van Sant, Eduardo Pascual
    Sun, Mary
    McIlvride, Alison
    Siddique, Maham
    Ha, Richard
    CLINICAL BREAST CANCER, 2020, 20 (06) : E757 - E760
  • [49] Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis
    Ryser, Marc D.
    Worni, Mathias
    Turner, Elizabeth L.
    Marks, Jeffrey R.
    Durrett, Rick
    Hwang, E. Shelley
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (05):
  • [50] Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ
    Grimm, Lars J.
    Ghate, Sujata V.
    Hwang, E. Shelley
    Soo, Mary Scott
    ACADEMIC RADIOLOGY, 2017, 24 (11) : 1364 - 1371
12345